SHL Telemedicine (NASDAQ:SHLT) Shares Down 9.7% – Here’s What Happened

SHL Telemedicine Ltd. (NASDAQ:SHLT)’s share price fell 9.7% on Friday . The stock traded as low as $2.54 and last traded at $2.62. 10,728 shares traded hands during mid-day trading, an increase of 207% from the average session volume of 3,495 shares. The stock had previously closed at $2.90.

SHL Telemedicine Trading Down 9.7 %

The firm has a 50 day moving average of $3.25 and a two-hundred day moving average of $4.26. The company has a debt-to-equity ratio of 0.19, a current ratio of 2.17 and a quick ratio of 1.98.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in SHL Telemedicine stock. Y.D. More Investments Ltd acquired a new position in SHL Telemedicine Ltd. (NASDAQ:SHLT) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 2,219,610 shares of the company’s stock, valued at approximately $11,351,000. SHL Telemedicine makes up approximately 1.2% of Y.D. More Investments Ltd’s holdings, making the stock its 22nd biggest position. Y.D. More Investments Ltd owned about 15.12% of SHL Telemedicine at the end of the most recent reporting period. Institutional investors own 20.11% of the company’s stock.

About SHL Telemedicine

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; and Cardio'B, a portable device to transmit a 12-lead ECG.